Skip to main content
. 2022 Dec 7;18(7):2150030. doi: 10.1080/21645515.2022.2150030

Figure 2.

Figure 2.

Geometric mean anti-Vi IgG antibody titers measured by ELISA (Group 1: Typbar-TCV® and MV co-administered at 9 months; Group 2: MV administered at 9 months and Typbar-TCV® at 10 months; Group 3: Typbar-TCV® administered at 8 months and MV at 9 months; and Group 4: only MV administered at 9 months. To assess TCV booster doses Group 1 was stratified into Group 1A, given a TCV booster at 10 months of age (28 ± 2 days after the first dose) and Group 1B, given a TCV booster at 15 months of age (180 ± 15 days post the first dose).